Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: A prospective study.
Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
Trigeminal neuralgia: A new therapy?
Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function?
Lysophospholipids and their receptors in the central nervous system.
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.
Multiple sclerosis: Pegylated IFN-β1a could lessen patients' injection burden.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
The Olig family affects central nervous system development and disease.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis.
Dimethyl fumarate associated lymphopenia in clinical practice.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
440
441
442
443
444
445
446
447
448
…
next ›
last »